Work

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course (P11-1.003)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211158

Authors: Tjalf Ziemssen, Katrin Schuh, Christian Hentschke, Gereon Nelles

Institutions: University Hospital Carl Gustav Carus, Novartis (Germany)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226734

FWCI:

Cites:

Cited by:

Related to: 10